The Limited Times

Now you can see non-English news...

Insomnia: with its drug, Idorsia promises a “revolution”


The Swiss biotech, created by a couple of French “serial entrepreneurs”, is launching its treatment against insomnia, Quviviq, in Europe.

It is a drug that could change the daily life of patients suffering from chronic insomnia.

A real revolution,

enthuses Jean-Paul Clozel, the French CEO of Idorsia, the Swiss biotech behind this drug.

The Quviviq allows natural sleep at night while preserving the patient's quality of life during the day.

This is an important breakthrough for anyone who is afraid to go to bed because they fear sleeping poorly.


This is the culmination of 20 years of work, the result of a long journey of research and trial and error

", rejoices Martine Clozel, scientific director of Idorsia.

To discover

  • Taxes 2022: all about your tax return

Read also

Nocturnal awakenings: what to do to avoid the trap of chronic insomnia?

Available in the United States for two weeks, the drug has just obtained the green light from the European Medicines Agency.

It is the first treatment against insomnia authorized in the EU apart from sleeping pills which have existed for 30 years (Stilnox, Xanax…), for the most part generic.

Discussions have started with the health systems of many…

This article is for subscribers only.

You have 68% left to discover.

Cultivating your freedom is cultivating your curiosity.

Keep reading your article for €0.99 for the first month


Already subscribed?


Source: lefigaro

All business articles on 2022-05-24

You may like

News/Politics 2022-06-23T11:12:15.889Z

Trends 24h

Business 2022-06-25T10:37:47.381Z
Business 2022-06-25T08:07:04.522Z


© Communities 2019 - Privacy